Miner PB Jr - Search Results

1

Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide.

Rao SSC, Laitman AP, Miner PB Jr. Rao SSC, et al. Among authors: miner pb jr. Clin Transl Gastroenterol. 2023 Jul 1;14(7):e00598. doi: 10.14309/ctg.0000000000000598. Clin Transl Gastroenterol. 2023. PMID: 37162147 Free PMC article. Clinical Trial.

2

Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease.

Miner PB Jr. Miner PB Jr. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1648-1649. doi: 10.1016/j.cgh.2019.01.045. Epub 2019 Feb 1. Clin Gastroenterol Hepatol. 2019. PMID: 30716476 No abstract available.

3

Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation.

Miner PB Jr. Miner PB Jr. Drug Saf. 2019 May;42(5):603-615. doi: 10.1007/s40264-018-0781-9. Drug Saf. 2019. PMID: 30649746 Review.

4

Irritable Bowel Syndrome Symptoms Following Giardiasis.

Miner PB Jr. Miner PB Jr. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1416. doi: 10.1016/j.cgh.2018.08.058. Epub 2018 Aug 25. Clin Gastroenterol Hepatol. 2019. PMID: 30153520 No abstract available.

5

Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation.

Miner PB Jr. Miner PB Jr. Expert Opin Pharmacother. 2018 Aug;19(12):1381-1388. doi: 10.1080/14656566.2018.1508450. Epub 2018 Aug 21. Expert Opin Pharmacother. 2018. PMID: 30129377 Review.

6

Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome.

Miner PB Jr. Miner PB Jr. Expert Opin Pharmacother. 2018 Feb;19(2):177-183. doi: 10.1080/14656566.2018.1427733. Epub 2018 Jan 29. Expert Opin Pharmacother. 2018. PMID: 29376436 Review.

7

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

Goel G, King T, Daveson AJ, Andrews JM, Krishnarajah J, Krause R, Brown GJE, Fogel R, Barish CF, Epstein R, Kinney TP, Miner PB Jr, Tye-Din JA, Girardin A, Taavela J, Popp A, Sidney J, Mäki M, Goldstein KE, Griffin PH, Wang S, Dzuris JL, Williams LJ, Sette A, Xavier RJ, Sollid LM, Jabri B, Anderson RP. Goel G, et al. Among authors: miner pb jr. Lancet Gastroenterol Hepatol. 2017 Jul;2(7):479-493. doi: 10.1016/S2468-1253(17)30110-3. Epub 2017 May 11. Lancet Gastroenterol Hepatol. 2017. PMID: 28506538 Free PMC article. Clinical Trial.

8

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.

Miner PB Jr, Koltun WD, Wiener GJ, De La Portilla M, Prieto B, Shailubhai K, Layton MB, Barrow L, Magnus L, Griffin PH. Miner PB Jr, et al. Am J Gastroenterol. 2017 Apr;112(4):613-621. doi: 10.1038/ajg.2016.611. Epub 2017 Feb 7. Am J Gastroenterol. 2017. PMID: 28169285 Free PMC article. Clinical Trial.

9

Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.

Miner PB Jr, Camilleri M, Burton D, Achenbach H, Wan H, Dragone J, Mellgard B. Miner PB Jr, et al. Neurogastroenterol Motil. 2016 Sep;28(9):1341-8. doi: 10.1111/nmo.12832. Epub 2016 Jun 7. Neurogastroenterol Motil. 2016. PMID: 27270968 Clinical Trial.

10

New pharmacological treatment options for irritable bowel syndrome with constipation.

Nusrat S, Miner PB Jr. Nusrat S, et al. Among authors: miner pb jr. Expert Opin Emerg Drugs. 2015;20(4):625-36. doi: 10.1517/14728214.2015.1105215. Epub 2015 Nov 7. Expert Opin Emerg Drugs. 2015. PMID: 26548544 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page